成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 1404-93-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1404-93-9
Chemical Structure| 1404-93-9
Structure of 1404-93-9 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 1404-93-9 ]

Related Doc. of [ 1404-93-9 ]

Alternatived Products of [ 1404-93-9 ]
Product Citations

Product Details of [ 1404-93-9 ]

CAS No. :1404-93-9 MDL No. :MFCD03613611
Formula : C66H76Cl3N9O24 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 1485.71 Pubchem ID :-
Synonyms :
Vancomycin HCl(1:x)
Chemical Name :(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-Amino-2-oxoethyl)-44-[[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy]-10,19-dichloro-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-[[(2R)-4-methyl-2-(methylamino)-1-oxopentyl]amino]-2,5,24,38,39-pentaoxo-22H-8,11:18,21-Dietheno-23,36-(iminomethano)-13,16:31,35-dimetheno-1H,16H-[1,6,9]oxadiazacyclohexadecino[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic acid xhydrochloride

Safety of [ 1404-93-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1404-93-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1404-93-9 ]

[ 1404-93-9 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 80565-30-6 ]
  • [ 1404-93-9 ]
  • C79H82Cl3N9O24 [ No CAS ]
  • 2
  • [ 80565-30-6 ]
  • [ 1404-93-9 ]
  • N-4-(4’-chlorobiphenyl)methyl vancomycin [ No CAS ]
YieldReaction ConditionsOperation in experiment
10% The synthesis scheme for arriving at the glycopeptide derivative RV79 isdescribed below, and also provided at Figure 3. To a 40 mL vial equipped a stir bar was addedanhydrous DMF (20 mL) and DIPEA (0.20 mL). The resulting solution was heated to 65 ocon an incubated shaker and vancomycin·HCl (700 mg, 0.462 mmol) was added slowly inportions. Heating was continued until all ofvancomycin·HCl had dissolved (5-10 min). Thebeige colored solution was allowed to cool to room temperature at which point 4' -Chlorobiphenyl-4-carbaldehyde (0.1 g, 0.462 mmol) was added to the reaction mixture. The reactionmixture was allowed to stir overnight. MeOH (1.5 mL) and TFA (0.14 mL, 1.8 mmol) wereintroduced and stirring was further continued for at least 2 h. Borane tert-butylamine complex( 40 mg, 0.46 mmol) was added in portions and the reaction mixture was stirred at ambienttemperature for an additional2 h. After the reaction completed, the reaction mixture is purifiedusing reverse phase C 18 column chromatography (Phenomenex Luna 10 uM PREP C 18(2) 250x 21.2 mm column) using gradients of water and acetonitrile, each containing 0.1% ( v /v) ofTF A Fractions were evaluated using HPLC and then pertinent fractions containing RV79were pooled together for isolation of the product via lyophilization. The target compound, RV79 (81.2 mg, 0.05 mmol, 10% overall yield), was obtained as a white solid in >97% purity(by HPLC). The reaction scheme is shown at Figure 3
Recommend Products
Same Skeleton Products
Historical Records
; ;